
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Global burden, temporal trends, and health workforce correlations of gallbladder and biliary tract cancer: a comprehensive analysis from 1990 to 2021 with projections to 2046 - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5343268AF3FB43054326004B1D884A.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="bmcgast">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12363135/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="BMC Gastroenterology">
<meta name="citation_title" content="Global burden, temporal trends, and health workforce correlations of gallbladder and biliary tract cancer: a comprehensive analysis from 1990 to 2021 with projections to 2046">
<meta name="citation_author" content="Fangyi Dai">
<meta name="citation_author_institution" content="Department of gastrointestinal Surgery, The First Affiliated Hospital of Kunming Medical University, Yun nan, 650032 China">
<meta name="citation_author" content="Huayou Luo">
<meta name="citation_author_institution" content="Department of gastrointestinal Surgery, The First Affiliated Hospital of Kunming Medical University, Yun nan, 650032 China">
<meta name="citation_author" content="Yuzhou Cai">
<meta name="citation_author_institution" content="Department of gastrointestinal Surgery, The First Affiliated Hospital of Kunming Medical University, Yun nan, 650032 China">
<meta name="citation_author" content="Yong Dai">
<meta name="citation_author_institution" content="Department of hepatobiliary Surgery, The Affiliated Hospital of Qinghai University, Qing hai, 810006 China">
<meta name="citation_publication_date" content="2025 Aug 18">
<meta name="citation_volume" content="25">
<meta name="citation_firstpage" content="596">
<meta name="citation_doi" content="10.1186/s12876-025-04121-5">
<meta name="citation_pmid" content="40826385">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12363135/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12363135/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12363135/pdf/12876_2025_Article_4121.pdf">
<meta name="description" content="Gallbladder and biliary tract cancers (GBTCs) represent aggressive malignancies with poor prognosis and rising global incidence. While previous studies have examined disease burden patterns, the relationship between health workforce capacity and ...">
<meta name="og:title" content="Global burden, temporal trends, and health workforce correlations of gallbladder and biliary tract cancer: a comprehensive analysis from 1990 to 2021 with projections to 2046">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Gallbladder and biliary tract cancers (GBTCs) represent aggressive malignancies with poor prognosis and rising global incidence. While previous studies have examined disease burden patterns, the relationship between health workforce capacity and ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12363135/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12363135">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12876-025-04121-5"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12876_2025_Article_4121.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12363135%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12363135/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12363135/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12363135/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-bmcgast.png" alt="BMC Gastroenterology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to BMC Gastroenterology" title="Link to BMC Gastroenterology" shape="default" href="https://bmcgastroenterol.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">BMC Gastroenterol</button></div>. 2025 Aug 18;25:596. doi: <a href="https://doi.org/10.1186/s12876-025-04121-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12876-025-04121-5</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22BMC%20Gastroenterol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22BMC%20Gastroenterol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22BMC%20Gastroenterol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22BMC%20Gastroenterol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Global burden, temporal trends, and health workforce correlations of gallbladder and biliary tract cancer: a comprehensive analysis from 1990 to 2021 with projections to 2046</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dai%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Fangyi Dai</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Fangyi Dai</span></h3>
<div class="p">
<sup>1</sup>Department of gastrointestinal Surgery, The First Affiliated Hospital of Kunming Medical University, Yun nan, 650032 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dai%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fangyi Dai</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Luo%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Huayou Luo</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Huayou Luo</span></h3>
<div class="p">
<sup>1</sup>Department of gastrointestinal Surgery, The First Affiliated Hospital of Kunming Medical University, Yun nan, 650032 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Luo%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Huayou Luo</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cai%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Yuzhou Cai</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Yuzhou Cai</span></h3>
<div class="p">
<sup>1</sup>Department of gastrointestinal Surgery, The First Affiliated Hospital of Kunming Medical University, Yun nan, 650032 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cai%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuzhou Cai</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dai%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Yong Dai</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Yong Dai</span></h3>
<div class="p">
<sup>2</sup>Department of hepatobiliary Surgery, The Affiliated Hospital of Qinghai University, Qing hai, 810006 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dai%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yong Dai</span></a>
</div>
</div>
<sup>2,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of gastrointestinal Surgery, The First Affiliated Hospital of Kunming Medical University, Yun nan, 650032 China </div>
<div id="Aff2">
<sup>2</sup>Department of hepatobiliary Surgery, The Affiliated Hospital of Qinghai University, Qing hai, 810006 China </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 27; Accepted 2025 Jun 27; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12363135  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40826385/" class="usa-link">40826385</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Gallbladder and biliary tract cancers (GBTCs) represent aggressive malignancies with poor prognosis and rising global incidence. While previous studies have examined disease burden patterns, the relationship between health workforce capacity and GBTC outcomes remains unexplored, representing a critical knowledge gap in understanding healthcare system determinants of disease management effectiveness.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">We conducted a comprehensive epidemiological analysis using Global Burden of Disease Study 2021 data from 204 countries and territories (1990–2021). Age-standardized rates and absolute numbers for incidence, prevalence, mortality, and disability-adjusted life years were analyzed. Advanced statistical approaches included age-period-cohort modeling, decomposition analysis, health inequality assessment, frontier analysis, and novel correlations between 22 health workforce categories and disease burden. Bayesian age-period-cohort modeling projected trends to 2046.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">Globally, incident cases increased from 107,798 to 216,768, while age-standardized incidence rates declined (EAPC: -0.45%, 95% CI: -0.48 to -0.41). Males showed increasing incidence trends (EAPC: 0.22%) contrasting with declining female patterns (EAPC: -0.91%). Population growth contributed 76.7% to absolute burden increases, aging added 43.3%, while epidemiological improvements reduced burden by 19.9%. Health workforce analysis revealed paradoxical positive correlations between conventional healthcare personnel density and disease burden (physicians/community health workers: <em>r</em> = 0.61 for incidence, <em>r</em> = 0.47 for mortality), while traditional practitioners showed consistent negative correlations (<em>r</em>=-0.17 for incidence, <em>r</em>=-0.25 for mortality). Slope inequality indices increased from 2.62 to 3.45 for incidence, indicating widening absolute disparities. Projections suggest incident cases will reach 387,000 by 2046.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par4">Despite declining age-standardized rates, absolute GBTC burden continues rising due to demographic transitions. The novel finding of paradoxical health workforce correlations challenges conventional assumptions about resource allocation effectiveness, suggesting that diagnostic capacity rather than workforce density per se determines reported disease burden. These insights inform evidence-based strategies for optimal resource allocation and targeted interventions addressing persistent global health inequalities.</p></section><section id="sec5"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s12876-025-04121-5.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Gallbladder cancer, Biliary tract neoplasms, Global health, Health workforce, Disease burden</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par5">Gallbladder and biliary tract cancers (GBTCs) represent a heterogeneous group of aggressive malignancies arising from the intrahepatic or extrahepatic bile ducts and the gallbladder, generally characterized by poor prognosis and rising incidence worldwide [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. These malignancies encompass intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma, each presenting distinct epidemiological patterns and therapeutic challenges [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>–<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. Despite advances in diagnostic and therapeutic approaches, most patients present with locally advanced or metastatic disease, resulting in limited treatment options and unfavorable outcomes.</p>
<p id="Par6">The global burden of GBTCs has demonstrated complex temporal patterns over the past three decades. While absolute case numbers have nearly doubled from 107,798 incident cases in 1990 to 216,768 in 2021, age-standardized incidence rates have shown a declining trend with an estimated annual percentage change of −0.45% globally. However, this overall trend masks significant regional heterogeneity, with high socio-demographic index countries experiencing declining rates while low and low-middle SDI regions show increasing burden [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. The disease burden varies substantially across geographical regions, with the highest rates consistently observed in the “gallbladder cancer belt” extending from South America through Asia, particularly in Chile, Republic of Korea, and Thailand.</p>
<p id="Par7">Recent epidemiological studies have revealed striking disparities in disease patterns between sexes and across different populations. While traditionally considered more prevalent in females, recent trends suggest a shifting paradigm with males showing increasing incidence rates and females demonstrating declining patterns [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Risk factor profiles vary considerably across populations, with gallstone disease [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]primary sclerosing cholangitis, and chronic inflammatory conditions established as significant risk factors [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>–<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Additionally, novel associations have emerged, including the protective effect of tea consumption (hazard ratio 0.77 for gallbladder cancer) and reproductive factors such as premature menopause before age 40 being associated with increased risk [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>].</p>
<p id="Par8">The therapeutic landscape for advanced GBTCs has undergone significant transformation with the integration of immunotherapy. Recent landmark clinical trials have established immunotherapy-based combinations as new standards of care. The KEYNOTE-966 trial demonstrated that pembrolizumab plus gemcitabine and cisplatin significantly improved overall survival compared to chemotherapy alone, with median survival extending from 10.9 to 12.7 months [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. Similarly, the TOPAZ-1 study showed sustained benefits with durvalumab plus chemotherapy, achieving improved survival outcomes with manageable safety profiles [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>].</p>
<p id="Par9">Healthcare system performance and resource allocation significantly impact GBTC outcomes, with substantial variations observed across countries with similar socio-demographic development levels. The increasing absolute disease burden due to population growth and aging, coupled with persistent health inequalities across socio-demographic strata, necessitates comprehensive analysis to optimize prevention and control strategies. Despite therapeutic advances, several critical knowledge gaps persist regarding the complex interplay between demographic transitions, evolving risk factor exposures, and healthcare system capabilities.</p>
<p id="Par10">The present study addresses these knowledge gaps by conducting a comprehensive epidemiological analysis of global GBTC burden patterns from 1990 to 2021, utilizing data from the Global Burden of Disease Study 2021. Through advanced statistical modeling approaches, including age-period-cohort analysis, decomposition analysis, frontier analysis, and health workforce correlation analysis, we aim to elucidate the complex temporal trends, driving forces, healthcare system performance, and the critical relationship between health workforce capacity and disease management effectiveness. This novel approach of examining associations between 22 different categories of health workforce density and GBTC burden provides unprecedented insights into human resource determinants of disease outcomes, informing evidence-based strategies for optimal resource allocation, prevention, and improved patient outcomes on a global scale.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Data sources and study design</h3>
<p id="Par11">This comprehensive epidemiological analysis utilized data from the Global Burden of Disease (GBD) Study 2021, which provides standardized estimates of disease burden for 204 countries and territories from 1990 to 2021. The GBD Study employs a systematic approach to synthesize data from multiple sources, including vital registration systems, cancer registries, population-based epidemiological studies, and administrative health records. For gallbladder and biliary tract cancer (International Classification of Diseases, 10th Revision codes C23, C24-C24.9), we extracted age-standardized rates (ASR) and absolute numbers for incidence, prevalence, mortality, and disability-adjusted life years (DALYs) stratified by sex, age groups (5-year intervals from 20 to 95 + years), and geographic location [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>].</p></section><section id="Sec4"><h3 class="pmc_sec_title">Burden measures and standardization</h3>
<p id="Par12">Four primary burden indicators were analyzed: (1) incidence, representing new cases diagnosed annually; (2) prevalence, indicating the total number of individuals living with the condition; (3) mortality, encompassing deaths attributed to gallbladder and biliary tract cancer; and (4) DALYs, combining years of life lost due to premature mortality and years lived with disability. All rates were age-standardized to the GBD world population standard to enable valid temporal and geographic comparisons. Uncertainty intervals (UI) were calculated using the 25th and 97.5th percentiles of 1,000 draw-level estimates generated through the GBD modeling process [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>].</p></section><section id="Sec5"><h3 class="pmc_sec_title">Temporal trend analysis</h3>
<p id="Par13">Temporal trends from 1990 to 2021 were quantified using estimated annual percentage change (EAPC), calculated through log-linear regression models fitted to natural logarithm-transformed age-standardized rates. The EAPC was computed as (exp(β)−1)×100, where β represents the slope coefficient from the regression of ln(ASR) on calendar year. Confidence intervals for EAPC were derived using standard errors from the regression model. Trends were classified as increasing (EAPC &gt; 0 with lower 95% CI &gt; 0), decreasing (EAPC &lt; 0 with upper 95% CI &lt; 0), or stable (95% CI includes 0).</p></section><section id="Sec6"><h3 class="pmc_sec_title">Age-period-cohort modeling</h3>
<p id="Par14">Age-period-cohort (APC) analysis was performed using intrinsic estimator methods to decompose temporal trends into age effects (biological aging), period effects (environmental changes affecting all age groups simultaneously), and cohort effects (exposures during specific birth periods). The analysis included individuals aged 20–99 years across 5-year age groups, 5-year calendar periods (1992–2021), and birth cohorts (1897–2001). Relative risks with 95% confidence intervals were calculated for each component, with statistical significance assessed at <em>p</em> &lt; 0.05.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Decomposition analysis</h3>
<p id="Par15">Changes in absolute disease burden from 1990 to 2021 were decomposed into three components using standardized demographic methods: (1) population growth effects, representing changes due to increased population size; (2) population aging effects, reflecting demographic transitions toward older age structures; and (3) epidemiological changes, capturing alterations in age-specific disease rates. The decomposition was calculated as: Total change = Population growth + Population aging + Epidemiological change, with percentage contributions computed for each component [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>].</p></section><section id="Sec8"><h3 class="pmc_sec_title">Health inequality assessment</h3>
<p id="Par16">Socioeconomic inequalities in disease burden were quantified using two complementary measures: (1) the slope index of inequality (SII), measuring absolute differences in disease rates between highest and lowest SDI countries; and (2) the concentration index (CI), assessing relative inequalities in the distribution of disease burden across the SDI spectrum. Both indices range from negative to positive values, with values closer to zero indicating greater equality. Concentration curves were plotted to visualize inequality patterns, with statistical significance tested using bootstrap methods.</p></section><section id="Sec9"><h3 class="pmc_sec_title">Frontier analysis</h3>
<p id="Par17">Healthcare system performance was evaluated through stochastic frontier analysis, which estimates the theoretical minimum disease burden achievable at each SDI level. The frontier represents optimal performance given available resources and development constraints. Effective differences were calculated as the gap between observed disease burden and frontier estimates, indicating potential for improvement. Countries were ranked by effective differences to identify best and worst performers relative to their development level.</p></section><section id="Sec10"><h3 class="pmc_sec_title">Health workforce correlation analysis</h3>
<p id="Par18">Associations between health workforce density and disease burden were assessed using Pearson correlation coefficients across 22 health workforce categories, including physicians, nurses, dentists, pharmacists, traditional practitioners, and allied health professionals. Health workforce data were obtained from WHO Global Health Workforce Statistics and expressed as density per 1,000 population. Correlation analyses were stratified by time period (1990 vs. 2019) and statistical significance was evaluated at <em>p</em> &lt; 0.05 with Bonferroni correction for multiple comparisons [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>].</p></section><section id="Sec11"><h3 class="pmc_sec_title">Prediction modeling</h3>
<p id="Par19">Future disease burden projections to 2046 were generated using Bayesian Age-Period-Cohort (BAPC) models implemented in R software using the BAPC package. The BAPC approach represents an advanced extension of classical age-period-cohort modeling that incorporates Bayesian inference framework to account for parameter uncertainty and provide probabilistic forecasts with credible intervals. The BAPC model decomposes the logarithm of age-specific rates into additive age, period, and cohort effects: log(λ_ac) = α_a + β_p + γ_c + ε, where λ_ac represents the rate for age group a in calendar period c, α_a denotes age effects, β_p represents period effects, γ_c indicates cohort effects, and ε represents random error. To address the inherent identifiability problem in APC models, the BAPC framework employs integrated nested Laplace approximations (INLA) with proper prior distributions that ensure model identifiability while maintaining interpretability. Prior distributions were specified as follows: age effects followed a second-order random walk prior to capture smooth age-related changes, period effects used a first-order random walk prior to model temporal trends, and cohort effects employed a second-order random walk prior to account for generational patterns. Hyperparameters controlling the smoothness of these effects were assigned weakly informative gamma priors with shape and rate parameters selected through empirical Bayes methods. Models were fitted separately for males and females to account for sex-specific disease patterns and risk factors. Model selection and hyperparameter tuning were performed using 5-fold cross-validation with deviance information criterion (DIC) as the primary selection metric. Convergence diagnostics included trace plots, effective sample size calculations, and Gelman-Rubin statistics to ensure adequate mixing of Markov chains.</p>
<p id="Par20">Future projections incorporated both parametric and non-parametric approaches: period effects were extrapolated using linear trends fitted to the most recent time periods, while cohort effects were projected using the established cohort patterns with appropriate uncertainty quantification. Prediction intervals were calculated using posterior distributions from Markov Chain Monte Carlo sampling with 10,000 iterations after 5,000 burn-in samples, providing 95% credible intervals for all projected estimates [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>].</p></section><section id="Sec12"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par21">All analyses were conducted using R version 4.3.0 (R Foundation for Statistical Computing, Vienna, Austria). Specific packages included: mgcv for generalized additive models, forecast for time series analysis, ggplot2 for visualization, and custom scripts for GBD data processing. Maps were created using the rnaturalearth and sf packages, with disease burden categories defined using natural breaks classification. Statistical significance was set at <em>p</em> &lt; 0.05 for all analyses, with appropriate corrections applied for multiple testing where applicable.</p></section><section id="Sec13"><h3 class="pmc_sec_title">Ethical considerations</h3>
<p id="Par22">This study utilized publicly available, deidentified, aggregate-level data from the GBD Study 2021. No individual-level data were accessed, and all analyses were conducted in accordance with the data use agreement for GBD estimates. Institutional review board approval was not required for this secondary analysis of publicly available aggregate data</p></section></section><section id="Sec14"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec15"><h3 class="pmc_sec_title">Global burden and temporal trends of gallbladder and biliary tract Cancer</h3>
<p id="Par23">Globally, gallbladder and biliary tract cancer demonstrated contrasting trends in age-standardized rates versus absolute case numbers from 1990 to 2021 (Fig. <a href="#Fig1" class="usa-link">1</a> and Table S1). While age-standardized incidence rates declined from 2.89 per 100,000 (95% UI: 2.59–3.15) to 2.56 per 100,000 (95% UI: 2.16–2.89) with an EAPC of −0.45% (95% CI: −0.48 to −0.41) (Fig. <a href="#Fig1" class="usa-link">1</a>A), the absolute number of incident cases nearly doubled from 107,798 to 216,768, reflecting global population growth and aging. Similarly, prevalence showed an increasing trend with age-standardized rates rising from 3.40 per 100,000 to 3.69 per 100,000 (EAPC: 0.26%) and absolute cases increasing from 130,026 to 314,465 (Fig. <a href="#Fig1" class="usa-link">1</a>B). This divergent pattern between incidence and prevalence trends suggests improvements in survival and case detection over the study period.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12363135_12876_2025_4121_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6103/12363135/83e21c841cb7/12876_2025_4121_Fig1_HTML.jpg" loading="lazy" id="d33e366" height="489" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Trends in gallbladder and biliary tract cancer burden from 1990 to 2021 across global regions and socio-demographic index levels (<strong>A</strong>) Incidence trends from 1990 to 2021 (<strong>B</strong>) Prevalence trends from 1990 to 2021 (<strong>C</strong>) DALYs trends from 1990 to 2021 (<strong>D</strong>) Deaths trends from 1990 to 2021</p></figcaption></figure><p id="Par25">Mortality patterns revealed more pronounced improvements, with age-standardized death rates declining from 2.69 per 100,000 to 2.04 per 100,000 (EAPC: −0.97%) (Fig. <a href="#Fig1" class="usa-link">1</a>D), while absolute deaths increased from 98,683 to 171,961. The disability-adjusted life years (DALYs) showed the most substantial improvement in age-standardized rates, decreasing from 58.58 per 100,000 to 43.21 per 100,000 (EAPC: −1.07%), though absolute DALYs increased from 2.33 million to 3.73 million (Fig. <a href="#Fig1" class="usa-link">1</a>C). The steeper decline in mortality and DALY rates compared to incidence rates indicates modest but consistent improvements in disease management and survival outcomes globally.</p>
<p id="Par26">Significant regional heterogeneity was observed across all burden measures, with a clear epidemiological transition pattern related to socio-demographic development. High SDI countries consistently demonstrated declining trends across all age-standardized measures (incidence EAPC: −0.77%, mortality EAPC: −1.59%, DALYs EAPC: −1.96%), while Low and Low-middle SDI countries showed increasing trends (incidence EAPC: 0.81% and 0.70%, respectively). Regionally, the highest burden in 2021 was observed in High-income Asia Pacific, Southern Latin America, and Andean Latin America, while the most significant improvements were seen in Central and Southern Latin America, Western Europe, and High-income Asia Pacific regions. Conversely, South Asia, Western Sub-Saharan Africa, and several low-development regions experienced increasing disease burden, highlighting the shift of gallbladder and biliary tract cancer burden toward less developed areas.</p></section><section id="Sec16"><h3 class="pmc_sec_title">Age-specific and sex-stratified disease patterns</h3>
<p id="Par27">Age-specific analysis revealed distinct temporal patterns across the lifespan, with gallbladder and biliary tract cancer demonstrating a characteristic bimodal trend in the oldest age groups (Fig. <a href="#Fig2" class="usa-link">2</a> and Table S2). For all burden measures, rates increased exponentially with age, peaking in the 80–84 years age group in 1990 and showing sustained elevation through the oldest age categories by 2021. Notably, while younger age groups (20–79 years) consistently showed declining trends across all indicators with EAPCs ranging from − 0.24% to −1.34%, the oldest age groups (85 + years) demonstrated either stable or increasing trends. The 95 + age group showed the most pronounced increases in incidence (EAPC: 1.66%), prevalence (EAPC: 1.94%), mortality (EAPC: 1.08%), and DALYs (EAPC: 1.01%), highlighting the growing burden among the very elderly population.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12363135_12876_2025_4121_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6103/12363135/f5969273c694/12876_2025_4121_Fig2_HTML.jpg" loading="lazy" id="d33e419" height="407" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Age-specific patterns of gallbladder and biliary tract cancer burden across all age groups globally, 1990 and 2021 (<strong>A</strong>) Incidence patterns by age in 1990 (<strong>B</strong>) Prevalence patterns by age in 1990 (<strong>C</strong>) Mortality patterns by age in 1990 (<strong>D</strong>) DALYs patterns by age in 1990 (<strong>E</strong>) Incidence patterns by age in 2021 (<strong>F</strong>) Prevalence patterns by age in 2021 (<strong>G</strong>) Mortality patterns by age in 2021 (<strong>H</strong>) DALYs patterns by age in 2021</p></figcaption></figure><p id="Par29">Sex-stratified analysis revealed significant disparities in disease patterns and temporal trends between males and females. While males showed increasing incidence trends (EAPC: 0.22%) and prevalence trends (EAPC: 1.05%), females demonstrated declining incidence (EAPC: −0.91%) and prevalence (EAPC: −0.37%) patterns. Both sexes experienced improvements in mortality and DALY rates, but the magnitude of improvement was substantially greater in females (mortality EAPC: −1.32%, DALYs EAPC: −1.40%) compared to males (mortality EAPC: −0.43%, DALYs EAPC: −0.60%). These divergent patterns suggest different underlying risk factor exposures or treatment responses between sexes, with the traditional female predominance in gallbladder cancer appearing to diminish over the study period, while outcomes improved more dramatically in women than in men.</p></section><section id="Sec17"><h3 class="pmc_sec_title">Geographic distribution and country-level burden patterns</h3>
<p id="Par30">Country-level analysis revealed profound geographic heterogeneity in gallbladder and biliary tract cancer burden, with distinct regional clustering patterns maintained over the 31-year study period (Fig. <a href="#Fig3" class="usa-link">3</a>). The highest disease burden consistently concentrated in specific geographic corridors, particularly the “gallbladder cancer belt” extending from South America through Asia. In 1990, the most severely affected countries included Chile (17.50 per 100,000 incidence, 419.06 DALYs per 100,000), Republic of Korea (10.51 per 100,000 incidence, 237.21 DALYs per 100,000), and Czechia (7.59 per 100,000 incidence, 164.09 DALYs per 100,000). By 2021, while absolute rates declined in many high-burden countries, the geographic distribution pattern remained remarkably consistent, with Chile (9.01 per 100,000 incidence), Republic of Korea (8.12 per 100,000 incidence), and Thailand (7.11 per 100,000 incidence) continuing to demonstrate the highest burden levels.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12363135_12876_2025_4121_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6103/12363135/4820eafc71cc/12876_2025_4121_Fig3_HTML.jpg" loading="lazy" id="d33e451" height="409" width="669" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Regional distribution of age-standardized rates of gallbladder and biliary tract cancer across 204 countries and territories, 1990 and 2021 (<strong>A</strong>) Regional Distribution of Age-Standardized Incidence, 1990 (left) and 2021 (right) (<strong>B</strong>) Regional Distribution of Age-Standardized Prevalence, 1990 (left) and 2021 (right) (<strong>C</strong>) Regional Distribution of Age-Standardized DALYs, 1990 (left) and 2021 (right) (<strong>D</strong>) Regional Distribution of Age-Standardized Deaths, 1990 (left) and 2021 (right)</p></figcaption></figure><p id="Par32">Regional variations demonstrated both continuity and evolution in disease patterns across different burden measures. Southeast Asia, particularly Thailand, emerged as a persistent high-burden region with incidence rates increasing from 6.37 to 7.11 per 100,000 and prevalence from 6.51 to 8.89 per 100,000 between 1990 and 2021. South American countries, led by Chile and Bolivia, maintained their position as the most severely affected globally, though with substantial improvements over time—Chile’s DALY burden decreased dramatically from 419.06 to 168.03 per 100,000. Conversely, several regions showed concerning upward trends, including parts of Sub-Saharan Africa where countries like Zimbabwe and Sao Tome and Principe demonstrated increasing burden across multiple indicators. The geographic stability of high-burden areas suggests persistent environmental, genetic, or lifestyle risk factors that transcend temporal changes in healthcare systems and socioeconomic development, while the magnitude changes reflect improvements in disease management and evolving risk factor profiles within these endemic regions.</p></section><section id="Sec18"><h3 class="pmc_sec_title">Age-period-cohort effects on disease risk patterns</h3>
<p id="Par33">Age-period-cohort analysis revealed distinct temporal risk patterns that illuminate the complex interplay of aging, secular trends, and generational effects in gallbladder and biliary tract cancer burden (Fig. <a href="#Fig4" class="usa-link">4</a> and Table S3-5). Age effects demonstrated the expected exponential increase in relative risk across all burden measures, with the highest risks observed in the 90–94 years age group for incidence (RR: 5.57, 95% CI: 5.50–5.65), prevalence (RR: 4.34, 95% CI: 4.28–4.40), and mortality (RR: 6.50, 95% CI: 6.41–6.60), while DALYs peaked slightly earlier in the 75–79 years group (RR: 2.88, 95% CI: 2.87–2.88). Period effects revealed consistent increasing trends across successive time periods from 1992 to 1996 to 2017–2021, with the most recent period showing the highest relative risks for incidence (RR: 1.45, 95% CI: 1.44–1.46) and prevalence (RR: 1.54, 95% CI: 1.53–1.55), suggesting improving case detection and survival over time (Fig. <a href="#Fig4" class="usa-link">4</a>A and B). Mortality and DALY period effects, while also increasing, showed more modest elevations (RR: 1.36 and 1.22, respectively), indicating genuine improvements in disease outcomes despite enhanced detection (Fig. <a href="#Fig4" class="usa-link">4</a>C and D).</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12363135_12876_2025_4121_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6103/12363135/6b7f7d93c096/12876_2025_4121_Fig4_HTML.jpg" loading="lazy" id="d33e489" height="420" width="798" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Age-period-cohort analysis of relative risk for gallbladder and biliary tract cancer burden globally from 1990 to 2021 (<strong>A</strong>) Relative risk of incidence from 1990 to 2021 (<strong>B</strong>) Relative risk of prevalence from 1990 to 2021 (<strong>C</strong>) Relative risk of mortality from 1990 to 2021 (<strong>D</strong>) Relative risk of DALYs from 1990 to 2021</p></figcaption></figure><p id="Par35">Cohort effects demonstrated a pronounced generational pattern, with individuals born in earlier cohorts (1897–1916) exhibiting substantially higher relative risks across all measures compared to those born in more recent decades. The most striking cohort effect was observed in the 1897–1901 birth cohort, showing elevated risks for incidence (RR: 3.50, 95% CI: 3.24–3.78), prevalence (RR: 3.47, 95% CI: 3.14–3.83), mortality (RR: 3.68, 95% CI: 3.42–3.95), and DALYs (RR: 2.42, 95% CI: 2.36–2.48). Sex-stratified analysis revealed differential cohort patterns between males and females, with males showing more pronounced early cohort effects and steeper declines in recent birth cohorts. The consistent decline in relative risk among successive birth cohorts born after 1920 suggests substantial improvements in early-life risk factor exposures, potentially including reduced infections, improved nutrition, and better socioeconomic conditions during formative years, which collectively contributed to the observed temporal trends in disease burden across different age groups and time periods.</p></section><section id="Sec19"><h3 class="pmc_sec_title">Driving forces behind global disease burden changes</h3>
<p id="Par36">Decomposition analysis revealed that population growth and aging were the primary drivers of increasing absolute gallbladder and biliary tract cancer burden globally, while epidemiological changes contributed to overall burden reduction through improved disease management and risk factor profiles (Fig. <a href="#Fig5" class="usa-link">5</a> and Table S6). At the global level, population growth accounted for 76.7% of the increase in incident cases, aging contributed an additional 43.3%, while epidemiological improvements offset these increases by reducing burden by 19.9%. This pattern was consistently observed across different socio-demographic index levels, with high SDI countries showing the most pronounced epidemiological improvements (−43.4% for incidence) but also experiencing substantial aging effects (76.6%), while low and low-middle SDI countries demonstrated modest epidemiological deterioration, suggesting ongoing challenges in disease prevention and management in these regions (Fig. <a href="#Fig5" class="usa-link">5</a>A). Similar patterns were observed for prevalence changes, where global population growth contributed 60.1% to increased cases, aging added 31.9%, and epidemiological factors provided a modest 8.0% improvement (Fig. <a href="#Fig5" class="usa-link">5</a>B).</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12363135_12876_2025_4121_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6103/12363135/2196921d1e64/12876_2025_4121_Fig5_HTML.jpg" loading="lazy" id="d33e527" height="564" width="789" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Decomposition analysis of gallbladder and biliary tract cancer burden changes across global regions and socio-demographic index levels from 1990 to 2021 (<strong>A</strong>) Decomposition of incidence changes from 1990 to 2021 (<strong>B</strong>) Decomposition of prevalence changes from 1990 to 2021 (<strong>C</strong>) Decomposition of mortality changes from 1990 to 2021 (<strong>D</strong>) Decomposition of DALYs changes from 1990 to 2021</p></figcaption></figure><p id="Par38">Mortality and DALY burden changes demonstrated even more pronounced epidemiological improvements, highlighting genuine progress in disease outcomes despite demographic pressures. For mortality, while population growth contributed 97.6% to increased absolute deaths and aging added 56.9%, epidemiological improvements reduced mortality burden by 54.5% globally, with the most substantial improvements observed in high SDI countries (−164.8%) and significant reductions also seen in high-middle SDI regions (−90.2%) (Fig. <a href="#Fig5" class="usa-link">5</a>C). The DALY analysis revealed the most dramatic epidemiological improvements, with a global reduction of 68.9% offset by population growth (115.1%) and aging effects (53.9%). Notably, high SDI countries achieved remarkable epidemiological improvements in DALYs (−705.8%), while low and low-middle SDI countries showed positive epidemiological changes (12.4% and 13.7% respectively), indicating that even resource-limited settings have made progress in reducing disease impact per capita (Fig. <a href="#Fig5" class="usa-link">5</a>D). These findings underscore the dual challenge of managing increasing absolute disease burden due to demographic transitions while simultaneously achieving improvements in age-standardized outcomes through enhanced prevention, early detection, and treatment strategies.</p></section><section id="Sec20"><h3 class="pmc_sec_title">Socioeconomic inequalities in disease burden distribution</h3>
<p id="Par39">Health inequality analysis revealed persistent and, in some cases, widening disparities in gallbladder and biliary tract cancer burden across countries with different socioeconomic development levels between 1990 and 2021 (Fig. <a href="#Fig6" class="usa-link">6</a> and Table S7). The slope inequality index, measuring absolute inequalities, demonstrated increasing disparities for incidence (from 2.62 to 3.45, 95% CI: 2.88–4.03) and prevalence (from 3.07 to 4.84, 95% CI: 4.05–5.64), indicating that the absolute gap in disease burden between the most and least developed countries has widened over the three-decade period. Conversely, mortality and DALY burden showed more stable absolute inequalities, with slope indices remaining relatively unchanged for mortality (2.27 to 2.37) and slightly decreasing for DALYs (49.55 to 45.55), suggesting some convergence in fatal outcomes despite increasing disparities in disease occurrence. The concentration index, measuring relative inequalities, revealed a more nuanced pattern with modest reductions across all burden measures: incidence concentration index decreased from 0.53 to 0.49, prevalence from 0.59 to 0.57, mortality from 0.48 to 0.41, and DALYs from 0.42 to 0.32. This divergence between absolute and relative inequality trends suggests that while the proportional distribution of disease burden has become slightly more equitable, the absolute differences in disease rates between high and low socioeconomic countries have grown, reflecting both the overall increase in global disease burden and the varying capacity of different healthcare systems to prevent and manage gallbladder and biliary tract cancer effectively (Fig. <a href="#Fig6" class="usa-link">6</a>A-H).</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12363135_12876_2025_4121_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6103/12363135/5467b8378f9a/12876_2025_4121_Fig6_HTML.jpg" loading="lazy" id="d33e581" height="1015" width="698" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Health inequality analysis of gallbladder and biliary tract cancer burden across 204 countries and territories, 1990 and 2021 (<strong>A</strong>) Slope inequality index for crude incidence, 1990 and 2021 (<strong>B</strong>) Concentration index for crude incidence, 1990 and 2021 (<strong>C</strong>) Slope inequality index for crude prevalence, 1990 and 2021 (<strong>D</strong>) Concentration index for crude prevalence, 1990 and 2021 (<strong>E</strong>) Slope inequality index for crude mortality, 1990 and 2021 (<strong>F</strong>) Concentration index for crude mortality, 1990 and 2021 (<strong>G</strong>) Slope inequality index for crude DALYs, 1990 and 2021 (<strong>H</strong>) Concentration index for crude DALYs, 1990 and 2021</p></figcaption></figure></section><section id="Sec21"><h3 class="pmc_sec_title">Healthcare system performance and development potential</h3>
<p id="Par41">Frontier analysis revealed substantial heterogeneity in country-level performance relative to their socio-demographic development, identifying significant opportunities for improvement across all burden measures in 2021 (Fig. <a href="#Fig7" class="usa-link">7</a> and Table S8). The analysis demonstrated that most countries operated below the theoretical optimal frontier, with effective differences representing the gap between observed rates and the best-achievable performance for their development level. High-burden countries consistently showed the largest effective differences, with Chile exhibiting the greatest underperformance across all indicators (incidence effective difference: 9.01 per 100,000, prevalence: 11.97 per 100,000, mortality: 7.57 per 100,000, DALYs: 168.03 per 100,000), followed by Thailand, Republic of Korea, and other endemic regions. Conversely, several countries achieved near-optimal performance for their SDI level, particularly in Sub-Saharan Africa where countries like Chad, Niger, and Somalia approached the frontier despite low development indices, suggesting effective resource utilization within their constraints. The analysis revealed that development level alone does not determine disease burden outcomes, as countries with similar SDI values demonstrated markedly different performance levels. For instance, among high SDI countries, significant variation existed between optimal performers approaching the frontier and underperformers with substantial effective differences, indicating that healthcare system efficiency, resource allocation, and disease-specific interventions play crucial roles beyond overall development status (Fig. <a href="#Fig7" class="usa-link">7</a>A-D).</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12363135_12876_2025_4121_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6103/12363135/7e29d7aa7035/12876_2025_4121_Fig7_HTML.jpg" loading="lazy" id="d33e627" height="1016" width="742" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Frontier analysis of gallbladder and biliary tract cancer burden in relation to socio-demographic index across 204 countries and territories in 2021 (<strong>A</strong>) Frontier analysis of age-standardized incidence rate in 2021 (<strong>B</strong>) Frontier analysis of age-standardized incidence rate in 2021 (<strong>C</strong>) Frontier analysis of age-standardized prevalence rate in 2021 (<strong>D</strong>) Frontier analysis of age-standardized prevalence rate in 2021 (<strong>E</strong>) Frontier analysis of age-standardized mortality rate in 2021 (<strong>F</strong>) Frontier analysis of age-standardized mortality rate in 2021 (<strong>G</strong>) Frontier analysis of age-standardized DALYs rate in 2021 (<strong>H</strong>) Frontier analysis of age-standardized DALYs rate in 2021</p></figcaption></figure></section><section id="Sec22"><h3 class="pmc_sec_title">Health workforce capacity and disease management effectiveness</h3>
<p id="Par43">Building upon the healthcare system performance analysis, we conducted comprehensive correlation analyses between 22 different categories of health workforce density and gallbladder and biliary tract cancer burden across countries to identify key human resource determinants of disease outcomes (Fig. <a href="#Fig8" class="usa-link">8</a>). The analysis revealed consistently positive correlations between most health workforce categories and disease burden indicators, with correlation coefficients ranging from moderate to strong across all burden measures. The strongest positive correlations were observed for physicians, clinical officers, and community health workers (CHWs) combined, with correlation coefficients of 0.61 for incidence (<em>p</em> &lt; 0.001), 0.69 for prevalence (<em>p</em> &lt; 0.001), 0.47 for mortality (<em>p</em> &lt; 0.001), and 0.43 for DALYs (<em>p</em> &lt; 0.001) in 2019. Similar patterns were observed across specialized healthcare personnel including dentists, medical laboratory technicians, and pharmaceutical personnel, suggesting that higher health workforce density paradoxically correlates with increased disease burden indicators, likely reflecting better case detection, diagnostic capacity, and reporting systems in countries with more developed healthcare infrastructure.</p>
<figure class="fig xbox font-sm" id="Fig8"><h4 class="obj_head">Fig. 8.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12363135_12876_2025_4121_Fig8_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6103/12363135/0dddbfd89d5c/12876_2025_4121_Fig8_HTML.jpg" loading="lazy" id="d33e663" height="593" width="669" alt="Fig. 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Correlation between health workforce density and gallbladder and biliary tract cancer burden indicators across countries, 1990 and 2021 (<strong>A</strong>) Correlation between physicians, clinical officers, and community health workers (CHWs) density and gallbladder and biliary tract cancer burden (<strong>B</strong>) Correlation between traditional and complementary practitioners density and gallbladder and biliary tract cancer burden</p></figcaption></figure><p id="Par45">Notably, traditional and complementary practitioners represented the only health workforce category demonstrating consistent negative correlations with disease burden across all indicators and time periods, with correlations of −0.17 for incidence (<em>p</em> = 0.014), −0.14 for prevalence (<em>p</em> = 0.048), −0.25 for mortality (<em>p</em> &lt; 0.001), and − 0.27 for DALYs (<em>p</em> &lt; 0.001) in 2019. This contrasting pattern became evident when examining extreme cases: countries with the highest disease burden, such as Chile (mortality: 8.26 per 100,000 with 30.04 physicians/CHWs per 1,000 vs. 1.02 traditional practitioners per 1,000 in 2019), Thailand (mortality: 6.32 per 100,000 with 7.99 physicians/CHWs per 1,000 vs. 1.33 traditional practitioners per 1,000), and Bolivia (mortality: 5.98 per 100,000 with 24.45 physicians/CHWs per 1,000 vs. 2.47 traditional practitioners per 1,000), demonstrated high conventional healthcare workforce density but relatively low traditional practitioner density. Conversely, countries with minimal disease burden, including Niger, Chad, and Gambia, exhibited the opposite pattern with very low conventional healthcare workforce density but proportionally higher traditional practitioner presence (Fig. <a href="#Fig8" class="usa-link">8</a>A and B).</p></section><section id="Sec24"><h3 class="pmc_sec_title">Bayesian age-period-cohort predictions to 2046</h3>
<p id="Par46">Bayesian Age-Period-Cohort (BAPC) modeling projected continued divergent trends between absolute case numbers and age-standardized rates for gallbladder and biliary tract cancer through 2046 (Fig. <a href="#Fig9" class="usa-link">9</a>). The models predicted substantial increases in absolute burden across all indicators, with incident cases projected to nearly double from 216,750 in 2021 to 387,000 by 2046, prevalence cases increasing from 314,407 to 484,223, deaths rising from 171,942 to 286,147, and DALYs growing from 3.73 million to 5.80 million. These projections underscore the dual challenge healthcare systems will face in managing an aging global population with increasing absolute disease burden while simultaneously achieving continued improvements in prevention and treatment effectiveness, with uncertainty intervals widening substantially toward 2046, reflecting inherent uncertainties in long-term epidemiological forecasting.</p>
<figure class="fig xbox font-sm" id="Fig9"><h4 class="obj_head">Fig. 9.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12363135_12876_2025_4121_Fig9_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6103/12363135/e7aa41de3253/12876_2025_4121_Fig9_HTML.jpg" loading="lazy" id="d33e710" height="803" width="669" alt="Fig. 9"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig9/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Projected gallbladder and biliary tract cancer burden globally from 1990 to 2046 (<strong>A</strong>) Projected incidence trends from 1990 to 2046 (<strong>B</strong>) Projected prevalence trends from 1990 to 2046 (<strong>C</strong>) Projected mortality trends from 1990 to 2046 (<strong>D</strong>) Projected DALYs trends from 1990 to 2046</p></figcaption></figure></section></section><section id="Sec25"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par48">Our comprehensive epidemiological analysis of gallbladder and biliary tract cancer burden from 1990 to 2021 reveals complex temporal patterns that both align with and extend previous findings in the literature. The observed decline in age-standardized incidence rates (EAPC: −0.45%) coupled with a near doubling of absolute case numbers reflects the dual impact of demographic transitions and epidemiological improvements, consistent with recent global burden assessments that have documented similar paradoxical trends in cancer epidemiology.</p>
<p id="Par49">The regional heterogeneity observed in our study, with high SDI countries experiencing declining trends while low and low-middle SDI regions show increasing burden, aligns with findings from recent studies examining global cancer inequalities. Our results corroborate the persistence of the “gallbladder cancer belt” extending from South America through Asia, with Chile, Republic of Korea, and Thailand maintaining the highest burden levels. This geographic stability suggests deeply rooted environmental, genetic, or lifestyle risk factors that transcend temporal changes in healthcare systems. A recent study by Zhou et al. specifically examining biliary tract cancer epidemiology in China reported rising trends in certain regions, particularly among males and older individuals, which is consistent with our findings of increased burden in low and middle SDI regions [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. Similarly, international trend analyses have documented rising intrahepatic cholangiocarcinoma mortality rates (APC: 3.1%) in several countries, supporting our observations of subtype-specific variations within the broader GBTC category [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>].</p>
<p id="Par50">The striking sex-specific temporal patterns revealed in our analysis represent a significant departure from traditional epidemiological understanding of GBTCs. While females have historically shown higher incidence rates, our findings demonstrate a convergence and potential reversal of this pattern, with males showing increasing incidence trends (EAPC: 0.22%) and females demonstrating declining patterns (EAPC: −0.91%). This finding is particularly noteworthy when considered alongside recent Korean cohort data demonstrating that premature menopause (before age 40) is associated with increased risk for both cholangiocarcinoma (adjusted HR 1.29, 95% CI: 1.01–1.64) and gallbladder cancer (adjusted HR 1.42, 95% CI: 1.03–1.97) [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. The observed sex disparities in our study may reflect changing hormonal exposures, occupational risk factors, or lifestyle patterns that differentially affect males and females over time. Additionally, recent molecular characterization studies have identified sex-specific mutational patterns and treatment responses, suggesting that biological differences may contribute to the observed epidemiological trends [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>].</p>
<p id="Par51">Our age-period-cohort analysis provides crucial insights into the temporal dynamics of GBTC burden, revealing distinct generational effects that have not been previously characterized at this scale. The pronounced cohort effects observed in earlier birth cohorts (1897–1916) with relative risks exceeding 3.0 for most burden measures suggest that early-life exposures during formative years significantly influence lifetime cancer risk. These findings complement recent studies examining environmental and lifestyle risk factors, including the protective association of tea consumption (HR: 0.77 for gallbladder cancer) and potential risks associated with coffee consumption observed in large-scale pooled analyses [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. The period effects demonstrating increasing relative risks across successive time periods (1992–2021) likely reflect improvements in diagnostic capabilities and case detection rather than genuine increases in disease occurrence, particularly given the concurrent improvements in survival outcomes.</p>
<p id="Par52">The decomposition analysis revealing that population growth contributed 76.7% to increased incident cases while epidemiological improvements offset burden by 19.9% globally provides quantitative evidence for the competing forces shaping contemporary cancer epidemiology. These findings are consistent with recent projections suggesting that demographic transitions will continue to drive absolute burden increases despite improvements in age-standardized rates. Studies examining future burden projections have similarly identified population aging as the primary driver of increasing absolute cancer cases, with epidemiological improvements providing modest mitigation [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. Our results extend these findings by quantifying the relative contributions across different SDI levels, revealing that high SDI countries achieve the most substantial epidemiological improvements (−43.4% for incidence) while simultaneously experiencing significant aging effects.</p>
<p id="Par53">The health inequality assessment revealing widening absolute disparities (slope inequality index increasing from 2.62 to 3.45 for incidence) despite modest improvements in relative inequalities (concentration index decreasing from 0.53 to 0.49) highlights the complex nature of global health equity in cancer care. These findings align with broader assessments of cancer inequalities demonstrating that while proportional distributions may improve, absolute gaps between high and low development countries often persist or widen. Recent analyses of biliary tract cancer burden across European countries have similarly documented substantial disparities in access to diagnostic tools and multidisciplinary care, particularly in economically disadvantaged regions [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. The persistence of these inequalities despite overall improvements in global health outcomes underscores the need for targeted interventions addressing both healthcare system capacity and upstream determinants of health.</p>
<p id="Par54">Our novel analysis of health workforce correlations reveals paradoxical patterns that challenge conventional assumptions about healthcare resource allocation and disease outcomes. The consistently positive correlations between most health workforce categories and disease burden indicators, with correlation coefficients ranging from 0.43 to 0.69 for physicians, clinical officers, and community health workers combined, likely reflect enhanced diagnostic capacity and reporting systems in countries with more developed healthcare infrastructure rather than causal relationships. This interpretation is supported by the observation that traditional and complementary practitioners demonstrated the only consistent negative correlations with disease burden across all indicators (correlation coefficients: −0.17 for incidence, −0.25 for mortality), suggesting either different practice patterns or populations served by these healthcare providers. These findings provide important insights for healthcare policy, indicating that simple increases in conventional healthcare workforce may not directly translate to reduced disease burden without corresponding improvements in prevention, early detection, and treatment effectiveness.</p>
<p id="Par55">The frontier analysis identifying substantial heterogeneity in country-level performance relative to socio-demographic development provides actionable insights for healthcare system optimization. Countries like Chile, Thailand, and Republic of Korea consistently demonstrated the largest effective differences across all burden measures, indicating significant opportunities for improvement despite their relatively high development levels. Conversely, several countries in Sub-Saharan Africa achieved near-optimal performance for their SDI level, suggesting effective resource utilization within existing constraints. These findings complement recent studies examining healthcare system efficiency in cancer care, which have similarly identified that development level alone does not determine disease outcomes, with healthcare system organization, resource allocation, and disease-specific interventions playing crucial roles [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>].</p>
<p id="Par56">Our predictive modeling extending to 2046 projects continued divergent trends between absolute burden and age-standardized rates, with incident cases expected to increase to 387,000 by 2046 while age-standardized rates continue declining. These projections align with recent Bayesian age-period-cohort predictions and other forecasting studies that have consistently identified demographic pressures as the primary driver of future cancer burden. The widening uncertainty intervals in our projections reflect inherent challenges in long-term epidemiological forecasting, particularly given evolving risk factor exposures, healthcare system capabilities, and potential therapeutic advances. Recent studies examining future cancer burden have emphasized the importance of strengthening prevention and early detection programs to mitigate the projected increases in absolute case numbers [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>].</p>
<p id="Par57">The clinical implications of our findings extend beyond epidemiological surveillance to inform evidence-based prevention and treatment strategies. The identification of persistent high-burden regions suggests the need for targeted interventions addressing specific environmental, genetic, or infectious risk factors. Recent therapeutic advances, including the demonstrated efficacy of pembrolizumab plus gemcitabine and cisplatin (median OS: 12.7 vs. 10.9 months, HR: 0.83) and durvalumab-based combinations (median OS: 12.9 vs. 11.3 months) in advanced disease, provide hope for improved outcomes [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>, <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. However, the persistent challenges in early detection and the limited benefit of these therapies in advanced disease underscore the critical importance of prevention and early intervention strategies.</p>
<p id="Par58">Based on our comprehensive findings, several actionable policy recommendations emerge for addressing the global GBTC burden. First, countries within the persistent ‘gallbladder cancer belt’ should prioritize targeted prevention programs including gallstone disease prevention initiatives, hepatitis B vaccination campaigns, and region-specific dietary modification programs. Second, given our novel health workforce correlation findings, policymakers should focus on enhancing diagnostic accuracy and early detection capabilities rather than simply expanding healthcare workforce numbers, while developing integrated care models that leverage both conventional and traditional healthcare providers where negative correlations were observed. Third, addressing the widening absolute health inequalities requires differential investment strategies that provide proportionally greater resources to low and middle SDI countries, coupled with international collaborative networks for knowledge transfer and capacity building. Fourth, anticipating our projections of nearly doubled case numbers by 2046, healthcare systems must develop comprehensive capacity planning strategies that account for both demographic pressures and epidemiological improvements, including age-appropriate screening protocols, geriatric care infrastructure expansion, and specialized biliary tract cancer care networks in high-burden regions.</p>
<p id="Par59">Several limitations of our study warrant consideration. First, the reliance on GBD estimates may introduce uncertainties related to data quality and modeling assumptions, particularly in regions with limited surveillance infrastructure. Second, the ecological nature of our health workforce correlation analysis precludes causal inferences and may be subject to confounding by unmeasured factors. Third, the heterogeneity within the GBTC category, encompassing distinct anatomical sites with different risk factors and prognoses, may mask important subtype-specific patterns. Fourth, our analysis does not account for recent molecular advances that have identified targetable alterations in approximately 34.3% of patients, including FGFR2 fusions and IDH1 mutations, which may influence future treatment paradigms and outcomes [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. Finally, the evolving landscape of risk factor exposures, including changing dietary patterns, environmental exposures, and infectious disease prevalence, may alter future disease patterns in ways not captured by historical trends.</p></section><section id="Sec26"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par60">
This comprehensive epidemiological analysis of global gallbladder and biliary tract cancer burden from 1990 to 2021 reveals complex temporal patterns characterized by declining age-standardized rates concurrent with substantially increasing absolute case numbers. The observed regional heterogeneity, with high socio-demographic index countries experiencing declining trends while low and middle SDI regions show increasing burden, highlights persistent global health inequalities that require targeted interventions. The striking sex-specific temporal patterns, with males showing increasing incidence trends and females demonstrating declining patterns, represent a significant departure from traditional epidemiological understanding and warrant further investigation into underlying mechanisms.</p>
<p id="Par61">Our age-period-cohort analysis demonstrates distinct generational effects with pronounced cohort impacts in earlier birth cohorts, suggesting that early-life exposures significantly influence lifetime cancer risk. The decomposition analysis quantifies population growth as the primary driver of increasing absolute burden, while epidemiological improvements provide modest global mitigation, with substantial variation across development levels. The health inequality assessment reveals widening absolute disparities despite improvements in relative inequalities, underscoring the complex nature of global health equity in cancer care.</p>
<p id="Par62">The novel health workforce correlation analysis reveals paradoxical patterns that challenge conventional assumptions about healthcare resource allocation and disease outcomes, suggesting that enhanced diagnostic capacity rather than causal relationships may explain the positive correlations between healthcare workforce density and reported disease burden. The frontier analysis identifies substantial opportunities for healthcare system optimization, with significant performance variations among countries with similar development levels.</p>
<p id="Par63">
Predictive modeling projects continued divergent trends through 2046, with absolute burden expected to nearly double while age-standardized rates continue declining, emphasizing the dual challenge of managing demographic pressures while achieving epidemiological improvements. These findings inform evidence-based strategies for prevention, early detection, and optimal resource allocation, highlighting the critical importance of addressing both healthcare system capacity and upstream determinants of health to effectively reduce the global burden of gallbladder and biliary tract cancers.</p>
<p id="Par64">The comprehensive insights provided by this analysis contribute to the understanding of global cancer epidemiology and provide a foundation for developing targeted interventions addressing the evolving challenges of gallbladder and biliary tract cancer burden in the context of demographic transitions, health system development, and persistent global inequalities.</p></section><section id="Sec27"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM1_ESM.docx</a><sup> (36.4KB, docx) </sup><p>Supplementary Material 1: Table S1: Incidence, prevalence, mortality, and DALYs associated with gallbladder and biliary tract cancer from 1990 to 2021, stratified by sex and across all global locations. The table includes the estimated average percent change (EAPC) over the period from 1990 to 2021.</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM2_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM2_ESM.docx</a><sup> (30.3KB, docx) </sup><p>Supplementary Material 2: Table S2: Detailed breakdown of gallbladder and biliary tract cancer incidence, prevalence, mortality, and DALYs from 1990 to 2019, categorized by sex and age group, with the EAPC for each indicator between 1990 and 2021.</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM3"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM3_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM3_ESM.docx</a><sup> (24.6KB, docx) </sup><p>Supplementary Material 3: Table S3: Age-period-cohort analysis presenting the relative risk (RR) of gallbladder and biliary tract cancer across both sexes over the study period.</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM4"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM4_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM4_ESM.docx</a><sup> (24.7KB, docx) </sup><p>Supplementary Material 4: Table S4: Age-period-cohort analysis showing the relative risk (RR) for gallbladder and biliary tract cancer specifically in males.</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM5"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM5_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM5_ESM.docx</a><sup> (24.7KB, docx) </sup><p>Supplementary Material 5: Table S5: Age-period-cohort analysis showing the relative risk (RR) for gallbladder and biliary tract cancer specifically in females.</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM6"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM6_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM6_ESM.docx</a><sup> (52.5KB, docx) </sup><p>Supplementary Material 6: Table S6: Analysis of changes in gallbladder and biliary tract cancer incidence from 1990 to 2021, attributed to population-level factors such as demographic shifts and epidemiological trends.</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM7"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM7_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM7_ESM.docx</a><sup> (17.9KB, docx) </sup><p>Supplementary Material 7: Table S7: Comparison of absolute and relative inequality indices for incidence, prevalence, mortality, and DALYs related to gallbladder and biliary tract cancer across all regions and for both sexes, contrasting 1990 with 2021.</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM8"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM8_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM8_ESM.docx</a><sup> (88.2KB, docx) </sup><p>Supplementary Material 8: Table S8: Frontier analysis of gallbladder and biliary tract cancer incidence rates, highlighting differences in burden and outcomes by country or territory, identifying variations in effectiveness and disease control.</p>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We are grateful for the work of the Global Burden of Disease study 2021 collaborators.</p></section><section id="notes1"><h2 class="pmc_sec_title">Authors’ contributions</h2>
<p>Conceptualization, F.D., Y.C.; Data management, F.D., H.L.; Methodology, F.D., H.L.; Software, F.D., Y.C.; Supervision, Y.D.; Writing—original draft, F.D., Y.C.; Writing—criticism and editing, F.D., Y.C.; Visualization, F.D., Y.C. All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>No funding.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The data used in this study came from a public database that everyone can access through the link provided in this article (https://vizhub.healthdata.org/gbd-results/).</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par65">Not applicable.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par66">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par67">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Valle JW, Kelley RK, Nervi B, Oh D-Y, Zhu AX. Biliary tract cancer. Lancet. 2021;397:428–44.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(21)00153-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33516341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Valle%20JW,%20Kelley%20RK,%20Nervi%20B,%20Oh%20D-Y,%20Zhu%20AX.%20Biliary%20tract%20cancer.%20Lancet.%202021;397:428%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Valle JW, et al. Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v28–37.
</cite> [<a href="https://doi.org/10.1093/annonc/mdw324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27664259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Valle%20JW,%20et%20al.%20Biliary%20cancer:%20ESMO%20clinical%20practice%20guidelines%20for%20diagnosis,%20treatment%20and%20follow-up.%20Ann%20Oncol.%202016;27:v28%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Banales JM, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557–88.
</cite> [<a href="https://doi.org/10.1038/s41575-020-0310-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7447603/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32606456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Banales%20JM,%20et%20al.%20Cholangiocarcinoma%202020:%20the%20next%20horizon%20in%20mechanisms%20and%20management.%20Nat%20Rev%20Gastroenterol%20Hepatol.%202020;17:557%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Lamarca A, Edeline J, Goyal L. How I treat biliary tract cancer. ESMO Open. 2022;7:100378.
</cite> [<a href="https://doi.org/10.1016/j.esmoop.2021.100378" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8762076/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35032765/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lamarca%20A,%20Edeline%20J,%20Goyal%20L.%20How%20I%20treat%20biliary%20tract%20cancer.%20ESMO%20Open.%202022;7:100378." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Lei S, et al. Global burden, trends, and inequalities of gallbladder and biliary tract cancer, 1990–2021: A decomposition and Age–Period–Cohort analysis. Liver Int. 2025;45:e16199.
</cite> [<a href="https://doi.org/10.1111/liv.16199" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11688657/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39742398/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lei%20S,%20et%20al.%20Global%20burden,%20trends,%20and%20inequalities%20of%20gallbladder%20and%20biliary%20tract%20cancer,%201990%E2%80%932021:%20A%20decomposition%20and%20Age%E2%80%93Period%E2%80%93Cohort%20analysis.%20Liver%20Int.%202025;45:e16199." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Jackson SS, et al. Menopausal hormone therapy and risk of biliary tract cancers. Hepatology. 2022;75:309–21.
</cite> [<a href="https://doi.org/10.1002/hep.32198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8766909/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34766362/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jackson%20SS,%20et%20al.%20Menopausal%20hormone%20therapy%20and%20risk%20of%20biliary%20tract%20cancers.%20Hepatology.%202022;75:309%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Ceci L, et al. Gallstone and gallbladder disease: biliary tract and cholangiopathies. In: Prakash YS, editor. Comprehensive physiology. Wiley; 2023. pp. 4909–43. 10.1002/cphy.c220028.</cite> [<a href="https://doi.org/10.1002/cphy.c220028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37358507/" class="usa-link">PubMed</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Bai Y, et al. Gastrointestinal traits, common inflammatory disorders, gallstones, and biliary tract cancer: A network Mendelian randomization study. J Adv Res. 2025;S2090123225001511. 10.1016/j.jare.2025.03.010.</cite> [<a href="https://doi.org/10.1016/j.jare.2025.03.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40064441/" class="usa-link">PubMed</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Banales JM, et al. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European network for the study of cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13:261–80.
</cite> [<a href="https://doi.org/10.1038/nrgastro.2016.51" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27095655/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Banales%20JM,%20et%20al.%20Cholangiocarcinoma:%20current%20knowledge%20and%20future%20perspectives%20consensus%20statement%20from%20the%20European%20network%20for%20the%20study%20of%20cholangiocarcinoma%20(ENS-CCA).%20Nat%20Rev%20Gastroenterol%20Hepatol.%202016;13:261%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Bridgewater J, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268–89.
</cite> [<a href="https://doi.org/10.1016/j.jhep.2014.01.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24681130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bridgewater%20J,%20et%20al.%20Guidelines%20for%20the%20diagnosis%20and%20management%20of%20intrahepatic%20cholangiocarcinoma.%20J%20Hepatol.%202014;60:1268%E2%80%9389." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Huang Y-H, et al. Association of tea and coffee consumption and biliary tract cancer risk: the biliary tract cancers pooling project. Hepatology. 2024;79:1324–36.
</cite> [<a href="https://doi.org/10.1097/HEP.0000000000000748" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11101691/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38758104/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20Y-H,%20et%20al.%20Association%20of%20tea%20and%20coffee%20consumption%20and%20biliary%20tract%20cancer%20risk:%20the%20biliary%20tract%20cancers%20pooling%20project.%20Hepatology.%202024;79:1324%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Maeng CH, Han K, Hong JY, Park J-H. Association between premature menopause and the risk of biliary tract cancer: A nationwide cohort study. Eur J Cancer. 2025;220:115387.
</cite> [<a href="https://doi.org/10.1016/j.ejca.2025.115387" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40158293/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maeng%20CH,%20Han%20K,%20Hong%20JY,%20Park%20J-H.%20Association%20between%20premature%20menopause%20and%20the%20risk%20of%20biliary%20tract%20cancer:%20A%20nationwide%20cohort%20study.%20Eur%20J%20Cancer.%202025;220:115387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Kelley RK, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;401:1853–65.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(23)00727-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37075781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kelley%20RK,%20et%20al.%20Pembrolizumab%20in%20combination%20with%20gemcitabine%20and%20cisplatin%20compared%20with%20gemcitabine%20and%20cisplatin%20alone%20for%20patients%20with%20advanced%20biliary%20tract%20cancer%20(KEYNOTE-966):%20a%20randomised,%20double-blind,%20placebo-controlled,%20phase%203%20trial.%20Lancet.%202023;401:1853%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Oh D-Y, et al. Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study. J Hepatol. 2025;S0168827825022019. 10.1016/j.jhep.2025.05.003.</cite> [<a href="https://doi.org/10.1016/j.jhep.2025.05.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40381735/" class="usa-link">PubMed</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Ferrari AJ, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2133–61.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(24)00757-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11122111/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38642570/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ferrari%20AJ,%20et%20al.%20Global%20incidence,%20prevalence,%20years%20lived%20with%20disability%20(YLDs),%20disability-adjusted%20life-years%20(DALYs),%20and%20healthy%20life%20expectancy%20(HALE)%20for%20371%20diseases%20and%20injuries%20in%20204%20countries%20and%20territories%20and%20811%20subnational%20locations,%201990%E2%80%932021:%20a%20systematic%20analysis%20for%20the%20global%20burden%20of%20disease%20study%202021.%20Lancet.%202024;403:2133%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Naghavi M, et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2100–32.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(24)00367-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11126520/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38582094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Naghavi%20M,%20et%20al.%20Global%20burden%20of%20288%20causes%20of%20death%20and%20life%20expectancy%20decomposition%20in%20204%20countries%20and%20territories%20and%20811%20subnational%20locations,%201990%E2%80%932021:%20a%20systematic%20analysis%20for%20the%20global%20burden%20of%20disease%20study%202021.%20Lancet.%202024;403:2100%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Brauer M, et al. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2162–203.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(24)00933-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11120204/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38762324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brauer%20M,%20et%20al.%20Global%20burden%20and%20strength%20of%20evidence%20for%2088%20risk%20factors%20in%20204%20countries%20and%20811%20subnational%20locations,%201990%E2%80%932021:%20a%20systematic%20analysis%20for%20the%20global%20burden%20of%20disease%20study%202021.%20Lancet.%202024;403:2162%E2%80%93203." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Cheng X, et al. Population ageing and mortality during 1990–2017: A global decomposition analysis. PLoS Med. 2020;17:e1003138.
</cite> [<a href="https://doi.org/10.1371/journal.pmed.1003138" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7279585/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32511229/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheng%20X,%20et%20al.%20Population%20ageing%20and%20mortality%20during%201990%E2%80%932017:%20A%20global%20decomposition%20analysis.%20PLoS%20Med.%202020;17:e1003138." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Haakenstad A, et al. Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2022;399:2129–54.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(22)00532-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9168805/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35617980/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Haakenstad%20A,%20et%20al.%20Measuring%20the%20availability%20of%20human%20resources%20for%20health%20and%20its%20relationship%20to%20universal%20health%20coverage%20for%20204%20countries%20and%20territories%20from%201990%20to%202019:%20a%20systematic%20analysis%20for%20the%20global%20burden%20of%20disease%20study%202019.%20Lancet.%202022;399:2129%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Knoll M, et al. An R package for an integrated evaluation of statistical approaches to cancer incidence projection. BMC Med Res Methodol. 2020;20:257.
</cite> [<a href="https://doi.org/10.1186/s12874-020-01133-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7559591/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33059585/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Knoll%20M,%20et%20al.%20An%20R%20package%20for%20an%20integrated%20evaluation%20of%20statistical%20approaches%20to%20cancer%20incidence%20projection.%20BMC%20Med%20Res%20Methodol.%202020;20:257." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Zhou J, et al. Epidemiology of biliary tract cancer in china: A narrative review. Chin J Cancer Res. 2024;36:474–88.
</cite> [<a href="https://doi.org/10.21147/j.issn.1000-9604.2024.05.02" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11555199/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39539810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20J,%20et%20al.%20Epidemiology%20of%20biliary%20tract%20cancer%20in%20china:%20A%20narrative%20review.%20Chin%20J%20Cancer%20Res.%202024;36:474%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Vu QT, et al. International trends in biliary tract cancer–related mortality, 2000–2022: an observational study of the world health organization mortality database. Hepatology. 2024. 10.1097/HEP.0000000000001200.
</cite> [<a href="https://doi.org/10.1097/HEP.0000000000001200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39700462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vu%20QT,%20et%20al.%20International%20trends%20in%20biliary%20tract%20cancer%E2%80%93related%20mortality,%202000%E2%80%932022:%20an%20observational%20study%20of%20the%20world%20health%20organization%20mortality%20database.%20Hepatology.%202024.%2010.1097/HEP.0000000000001200." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Yoon J, G, et al. Molecular characterization of biliary tract Cancer predicts chemotherapy and programmed death 1/programmed death-Ligand 1 Blockade responses. Hepatology. 2021;74:1914–31.</cite> [<a href="https://doi.org/10.1002/hep.31862" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33884649/" class="usa-link">PubMed</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Rimassa L, et al. Mapping the landscape of biliary tract cancer in europe: challenges and controversies. Lancet Reg Health - Europe. 2025;50:101171.
</cite> [<a href="https://doi.org/10.1016/j.lanepe.2024.101171" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11910794/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40093398/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rimassa%20L,%20et%20al.%20Mapping%20the%20landscape%20of%20biliary%20tract%20cancer%20in%20europe:%20challenges%20and%20controversies.%20Lancet%20Reg%20Health%20-%20Europe.%202025;50:101171." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Hwang S, et al. Concordance of ctdna and tissue genomic profiling in advanced biliary tract cancer. J Hepatol. 2025;82:649–57.
</cite> [<a href="https://doi.org/10.1016/j.jhep.2024.10.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39442892/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hwang%20S,%20et%20al.%20Concordance%20of%20ctdna%20and%20tissue%20genomic%20profiling%20in%20advanced%20biliary%20tract%20cancer.%20J%20Hepatol.%202025;82:649%E2%80%9357." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM1_ESM.docx</a><sup> (36.4KB, docx) </sup><p>Supplementary Material 1: Table S1: Incidence, prevalence, mortality, and DALYs associated with gallbladder and biliary tract cancer from 1990 to 2021, stratified by sex and across all global locations. The table includes the estimated average percent change (EAPC) over the period from 1990 to 2021.</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM2_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM2_ESM.docx</a><sup> (30.3KB, docx) </sup><p>Supplementary Material 2: Table S2: Detailed breakdown of gallbladder and biliary tract cancer incidence, prevalence, mortality, and DALYs from 1990 to 2019, categorized by sex and age group, with the EAPC for each indicator between 1990 and 2021.</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM3_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM3_ESM.docx</a><sup> (24.6KB, docx) </sup><p>Supplementary Material 3: Table S3: Age-period-cohort analysis presenting the relative risk (RR) of gallbladder and biliary tract cancer across both sexes over the study period.</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM4_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM4_ESM.docx</a><sup> (24.7KB, docx) </sup><p>Supplementary Material 4: Table S4: Age-period-cohort analysis showing the relative risk (RR) for gallbladder and biliary tract cancer specifically in males.</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM5_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM5_ESM.docx</a><sup> (24.7KB, docx) </sup><p>Supplementary Material 5: Table S5: Age-period-cohort analysis showing the relative risk (RR) for gallbladder and biliary tract cancer specifically in females.</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material6_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM6_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM6_ESM.docx</a><sup> (52.5KB, docx) </sup><p>Supplementary Material 6: Table S6: Analysis of changes in gallbladder and biliary tract cancer incidence from 1990 to 2021, attributed to population-level factors such as demographic shifts and epidemiological trends.</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material7_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM7_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM7_ESM.docx</a><sup> (17.9KB, docx) </sup><p>Supplementary Material 7: Table S7: Comparison of absolute and relative inequality indices for incidence, prevalence, mortality, and DALYs related to gallbladder and biliary tract cancer across all regions and for both sexes, contrasting 1990 with 2021.</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material8_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12363135/bin/12876_2025_4121_MOESM8_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">12876_2025_4121_MOESM8_ESM.docx</a><sup> (88.2KB, docx) </sup><p>Supplementary Material 8: Table S8: Frontier analysis of gallbladder and biliary tract cancer incidence rates, highlighting differences in burden and outcomes by country or territory, identifying variations in effectiveness and disease control.</p>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data used in this study came from a public database that everyone can access through the link provided in this article (https://vizhub.healthdata.org/gbd-results/).</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from BMC Gastroenterology are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12876-025-04121-5"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12876_2025_Article_4121.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (7.8 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12363135/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12363135/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12363135%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12363135/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12363135/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12363135/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40826385/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12363135/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40826385/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12363135/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12363135/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="RRvTs3JTaEMcX4v3QCwCSVnhBgSY7uUDFaS7c3vBeqn4L4wPwD5c3CvXORJcoN0d">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
